Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,132 | 802 | 77.0% |
| Travel and Lodging | $3,527 | 20 | 11.7% |
| Education | $1,927 | 1 | 6.4% |
| Consulting Fee | $1,040 | 1 | 3.5% |
| Unspecified | $410.00 | 1 | 1.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nevro Corp. | $4,438 | 57 | $0 (2024) |
| Medtronic, Inc. | $3,014 | 45 | $0 (2024) |
| Abbott Laboratories | $2,881 | 40 | $0 (2024) |
| Medtronic USA, Inc. | $2,658 | 44 | $0 (2020) |
| Arthrex, Inc. | $2,303 | 3 | $0 (2018) |
| Boston Scientific Corporation | $1,543 | 35 | $0 (2024) |
| ABBVIE INC. | $1,368 | 74 | $0 (2024) |
| SI-BONE, INC. | $1,291 | 16 | $0 (2024) |
| RedHill Biopharma Inc. | $1,182 | 9 | $0 (2023) |
| Vertiflex, Inc. | $981.76 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,604 | 75 | Medtronic, Inc. ($880.14) |
| 2023 | $3,154 | 122 | Nevro Corp. ($812.53) |
| 2022 | $5,054 | 131 | Nevro Corp. ($1,830) |
| 2021 | $5,300 | 127 | Abbott Laboratories ($1,334) |
| 2020 | $2,315 | 94 | Medtronic USA, Inc. ($552.79) |
| 2019 | $4,997 | 216 | Medtronic USA, Inc. ($1,334) |
| 2018 | $5,675 | 46 | Arthrex, Inc. ($2,303) |
| 2017 | $936.24 | 14 | Medtronic USA, Inc. ($340.27) |
All Payment Transactions
825 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $171.31 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/31/2024 | Medtronic, Inc. | VANTA ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $126.21 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/11/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Analgesic | ||||||
| 12/10/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $35.17 | General |
| Category: Not Applicable | ||||||
| 12/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $28.84 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Pain Management | ||||||
| 11/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/15/2024 | Boston Scientific Corporation | Clik X (Device) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Clik_NMD | ||||||
| 11/06/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.60 | General |
| Category: Opioid Analgesic | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Gastroenterology | ||||||
| 10/08/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Pain Management | ||||||
| 09/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $31.67 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 09/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Gastroenterology | ||||||
| 09/25/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Clinical Trial Product_NMD | ||||||
| 09/17/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/17/2024 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: PAIN | ||||||
| 09/10/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Pain Management | ||||||
| 08/28/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $103.32 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/27/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 08/21/2024 | PROTEGA PHARMACEUTIALS INC | ROXYBOND (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Pain Management | ||||||
| 08/21/2024 | Forte Bio-Pharma LLC | PROLATE (Drug), NALOCET, PROLATE | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: PAIN | ||||||
| 08/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.60 | General |
| Category: Opioid Analgesic | ||||||
| 08/14/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Spinal Cord Neurostimulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 3,586 | 20,245 | $4.3M | $615,123 |
| 2022 | 33 | 3,988 | 11,949 | $4.3M | $690,544 |
| 2021 | 33 | 3,658 | 8,463 | $4.0M | $567,908 |
| 2020 | 31 | 2,999 | 6,197 | $2.3M | $309,529 |
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 677 | 3,139 | $1.6M | $284,558 | 18.1% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 293 | 439 | $548,750 | $65,939 | 12.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 21 | 9,905 | $74,387 | $49,187 | 66.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 342 | 521 | $117,225 | $30,511 | 26.0% |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 102 | 106 | $159,000 | $19,730 | 12.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 66 | 75 | $216,000 | $15,803 | 7.3% |
| G0396 | Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes | Office | 2023 | 338 | 532 | $79,800 | $14,228 | 17.8% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 94 | 117 | $230,400 | $12,398 | 5.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $86,000 | $10,753 | 12.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 100 | 117 | $11,700 | $10,691 | 91.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 113 | 148 | $59,200 | $9,774 | 16.5% |
| J7329 | Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | Office | 2023 | 14 | 1,225 | $29,200 | $8,524 | 29.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 52 | 77 | $181,600 | $7,916 | 4.4% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 35 | 66 | $42,000 | $6,062 | 14.4% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 24 | 26 | $72,000 | $5,180 | 7.2% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 77 | 114 | $45,600 | $5,170 | 11.3% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 64 | 73 | $106,000 | $4,841 | 4.6% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 12 | 16 | $45,000 | $4,335 | 9.6% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Facility | 2023 | 32 | 36 | $71,200 | $4,311 | 6.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 18 | 39 | $23,400 | $4,274 | 18.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 145 | 429 | $42,900 | $4,263 | 9.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 48 | 73 | $86,000 | $4,232 | 4.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 33 | $17,736 | $4,093 | 23.1% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 70 | 85 | $80,800 | $4,017 | 5.0% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 24 | 33 | $74,400 | $3,775 | 5.1% |
About Dr. Adam Antflick, D.O
Dr. Adam Antflick, D.O is a Pain Medicine healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2012. The National Provider Identifier (NPI) number assigned to this provider is 1114274057.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Antflick, D.O has received a total of $30,036 in payments from pharmaceutical and medical device companies, with $2,604 received in 2024. These payments were reported across 825 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($23,132).
As a Medicare-enrolled provider, Antflick has provided services to 14,231 Medicare beneficiaries, totaling 46,854 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Las Vegas, NV
- Active Since 08/09/2012
- Last Updated 11/23/2020
- Taxonomy Code 207LP2900X
- Entity Type Individual
- NPI Number 1114274057
Products in Payments
- Omnia (Device) $2,188
- INTELLIS ADAPTIVESTIM (Device) $1,572
- Proclaim IPG (Device) $1,268
- Senza (Device) $1,184
- ADAPTIVESTIM (Device) $1,166
- MOVANTIK (Drug) $1,040
- MYSTIM (Device) $993.96
- iFuse Implant (Device) $992.47
- Superion ISS (Device) $981.76
- SPECTRA WAVEWRITER (Device) $939.85
- RELISTOR (Drug) $911.64
- BOTOX (Biological) $804.29
- Senza Spinal Cord Stimulation System (Device) $722.05
- UBRELVY (Drug) $668.31
- Morphabond ER (Drug) $658.70
- ZTLido (Drug) $644.00
- Proclaim Family of SCS IPGs (Device) $579.39
- VANTA ADAPTIVESTIM (Device) $461.30
- INTELLIS (Device) $459.93
- NURTEC ODT (Drug) $406.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Las Vegas
Dr. Neville Campbell, M.d, M.D
Pain Medicine — Payments: $22,235
Dr. Okwuchukwu Obi, Md, MD
Pain Medicine — Payments: $18,079
Andrew Kim, D.o., Pllc, D.O., PLLC
Pain Medicine — Payments: $16,861
Dr. Pouya Mohajer, M.d, M.D
Pain Medicine — Payments: $16,151
Christopher Fisher, Md, MD
Pain Medicine — Payments: $14,173
Dr. Peter Su, M.d, M.D
Pain Medicine — Payments: $11,084